144 related articles for article (PubMed ID: 10383938)
1. BALB/c.CBA/N mice carrying the defective Btk(xid) gene are resistant to pristane-induced plasmacytomagenesis.
Potter M; Wax JS; Hansen CT; Kenny JJ
Int Immunol; 1999 Jul; 11(7):1059-64. PubMed ID: 10383938
[TBL] [Abstract][Full Text] [Related]
2. Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility.
Zhang SL; DuBois W; Ramsay ES; Bliskovski V; Morse HC; Taddesse-Heath L; Vass WC; DePinho RA; Mock BA
Mol Cell Biol; 2001 Jan; 21(1):310-8. PubMed ID: 11113205
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin is a potent inhibitor of pristane and plastic disc induced plasmacytomagenesis in a hypersusceptible BALB/c congenic strain.
Potter M; Wax J; Jones GM
Blood; 1997 Jul; 90(1):260-9. PubMed ID: 9207461
[TBL] [Abstract][Full Text] [Related]
4. Pristane induces an indomethacin inhibitable inflammatory influx of CD4+ T cells and IFN-gamma production in plasmacytoma-susceptible BALB/cAnPt mice.
McDonald AH; Degrassi A
Cell Immunol; 1993 Jan; 146(1):157-70. PubMed ID: 8425224
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin inhibition of pristane plasmacytomagenesis in genetically susceptible inbred mice.
Potter M
Adv Exp Med Biol; 1999; 469():151-6. PubMed ID: 10667324
[No Abstract] [Full Text] [Related]
6. Elevated mutant frequencies in lymphoid tissues persist throughout plasmacytoma development in BALB/c.lambdaLIZ mice.
Felix K; Kelliher KA; Bornkamm GW; Janz S
Cancer Res; 1999 Aug; 59(15):3621-6. PubMed ID: 10446972
[TBL] [Abstract][Full Text] [Related]
7. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice.
Rawlings DJ; Saffran DC; Tsukada S; Largaespada DA; Grimaldi JC; Cohen L; Mohr RN; Bazan JF; Howard M; Copeland NG
Science; 1993 Jul; 261(5119):358-61. PubMed ID: 8332901
[TBL] [Abstract][Full Text] [Related]
8. Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice.
Potter M; Morrison S; Wiener F; Zhang XK; Miller FW
J Natl Cancer Inst; 1994 Jul; 86(14):1058-65. PubMed ID: 8021954
[TBL] [Abstract][Full Text] [Related]
9. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice.
Potter M; Mushinski EB; Wax JS; Hartley J; Mock BA
Cancer Res; 1994 Feb; 54(4):969-75. PubMed ID: 8313388
[TBL] [Abstract][Full Text] [Related]
10. Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane.
Byrd LG; McDonald AH; Gold LG; Potter M
J Immunol; 1991 Nov; 147(10):3632-7. PubMed ID: 1682379
[TBL] [Abstract][Full Text] [Related]
11. A new molecular genetic diagnosis of the Btk(xid) mice.
Takagi Y; Masui N; Yasuda M; Ono S
Exp Anim; 2007 Jan; 56(1):63-6. PubMed ID: 17283893
[TBL] [Abstract][Full Text] [Related]
12. A novel Tth111I restriction fragment length polymorphism (RFLP) allows tracing of X-chromosome inactivation in the (Xid) heterozygote.
Shanmugam V; Chapman VM; Sell KW; Saha BK
Biochem Genet; 1996 Feb; 34(1-2):17-29. PubMed ID: 8935990
[TBL] [Abstract][Full Text] [Related]
13. Differential susceptibility of BALB/c and DBA/2 cells to plasmacytoma induction in reciprocal chimeras.
Silva S; Sugiyama H; Babonits M; Wiener F; Klein G
Int J Cancer; 1991 Sep; 49(2):224-8. PubMed ID: 1879968
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous development of plasmacytomas in a selected subline of BALB/cJ mice.
Silva S; Wang Y; Babonits M; Imreh S; Wiener F; Klein G
Eur J Cancer; 1997 Mar; 33(3):479-85. PubMed ID: 9155535
[TBL] [Abstract][Full Text] [Related]
15. Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis.
Mock BA; Krall MM; Dosik JK
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9499-503. PubMed ID: 8105477
[TBL] [Abstract][Full Text] [Related]
16. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction.
Santos-Argumedo L; Lund FE; Heath AW; Solvason N; Wu WW; Grimaldi JC; Parkhouse RM; Howard M
Int Immunol; 1995 Feb; 7(2):163-70. PubMed ID: 7734414
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of plasmacytoma development in BALB/c mice by indomethacin.
Potter M; Wax JS; Anderson AO; Nordan RP
J Exp Med; 1985 May; 161(5):996-1012. PubMed ID: 3989472
[TBL] [Abstract][Full Text] [Related]
18. Macrophage effector functions controlled by Bruton's tyrosine kinase are more crucial than the cytokine balance of T cell responses for microfilarial clearance.
Mukhopadhyay S; Mohanty M; Mangla A; George A; Bal V; Rath S; Ravindran B
J Immunol; 2002 Mar; 168(6):2914-21. PubMed ID: 11884462
[TBL] [Abstract][Full Text] [Related]
19. xid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B cell development.
Cancro MP; Sah AP; Levy SL; Allman DM; Schmidt MR; Woodland RT
Int Immunol; 2001 Dec; 13(12):1501-14. PubMed ID: 11717191
[TBL] [Abstract][Full Text] [Related]
20. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S
Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
